Latin America represents one of the growing markets for life sciences companies. The biggest Latin American markets (Mexico, Brazil, Argentina, Peru, Chile, Venezuela and Colombia) represent a market of more than 427 million people with a GDP of greater than US$1.8 trillion reaching a market value of over US$45 billion at retail prices in 2010. With expanding populations and dynamic economies, populations are demanding greater quality and access to healthcare.  

Whether you're considering expansion into the region or already dealing with the regulatory complexities in these countries, Praxis can help.

Product dossier preparation (in English and local language)

Product country filings

Regulatory agency communications and follow-up

• Labeling strategy development and implementation
• Regulatory strategy development
• Regulatory advisory service
• Regulatory intelligence briefings